SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8Thanks for posting, IJ. The optimal dose of defibrotide is higher than I had exrareearth42-12/2/2006
7Good digging IJ..this company seems so well run with an excellent candidate and zeta1961-12/2/2006
6Gentium Reports Third Quarter Financial Results and Clinical Update Thursday NovIRWIN JAMES FRANKEL-11/30/2006
5[3560] A Multi-Center Phase I/II Study of Melphalan, Prednisone, Thalidomide andIRWIN JAMES FRANKEL-11/30/2006
4[43] Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) IRWIN JAMES FRANKEL-11/30/2006
3Gentium to Present Data Showing Defibrotide Modulates Immune Functions Tuesday SIRWIN JAMES FRANKEL-9/5/2006
2GENT's tape is the most "painted" one I have ever seen. The actioIRWIN JAMES FRANKEL-8/31/2006
1Take a look at this post for a comment about a week ago. Message 22649111 RE42rareearth42-7/29/2006
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News